title: Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen.
authors.affiliation: Departments of *Molecular Medicine; and †Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Falasca
authors.forename: Laura
authors.initials: L
authors.lastname: Mazzuti
authors.forename: Gabriella
authors.initials: G
authors.lastname: DʼEttorre
authors.forename: Francesca
authors.initials: F
authors.lastname: Paoletti
authors.forename: Omar
authors.initials: O
authors.lastname: Tripolino
authors.forename: Sara
authors.initials: S
authors.lastname: Serafino
authors.forename: Guido
authors.initials: G
authors.lastname: Antonelli
authors.forename: Ombretta
authors.initials: O
authors.lastname: Turriziani
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood*; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D011760:Pyrrolidinones / Q000627:therapeutic use*; D000068898:Raltegravir Potassium; D019562:Viral Load; D014766:Viremia
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium